Skip to main content
. Author manuscript; available in PMC: 2013 Dec 1.
Published in final edited form as: Atherosclerosis. 2012 Sep 13;225(2):388–396. doi: 10.1016/j.atherosclerosis.2012.09.001

Table 3.

Multivariate analysis for variables associated with changes in lathosterol and β-sitosterol after 6 weeks of ezetimibe add-on therapy

Factor Change in lathosterol Change in β-sitosterol
Beta P value Beta P value
- baseline total cholesterol 0.009 0.0350 0.002 0.1936
- baseline LDL-C 0.004 0.4538 0.005 0.0210
- changes in total cholesterol 0.026 <0.0001 0.012 <0.0001
- changes in LDL-C 0.001 0.8297 0.005 0.1015
- baseline lathosterol −0.409 <0.0001
- baseline β-sitosterol −0.540 <0.0001
- statin type 0.5976 0.7147
- statin potency
 high-potency −0.491 0.0065 0.201 0.0215
 medium-potency 0.000 0.000
 low-potency 0.230 0.004